New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareHumanin vs Bronchogen

Humanin vs Bronchogen

Side-by-side comparison of key properties, dosing, and research.

Anti-Aging & Longevity
Humanin
Anti-Aging & Longevity
Bronchogen
Summary
Humanin is a mitochondria-derived peptide (MDP) encoded in the 16S rRNA region of the mitochondrial genome. It protects neurons and other cells from apoptosis, improves insulin sensitivity, and declines significantly with age. HNG (S14G-Humanin) is a synthetic analog with 1000x greater potency.
Bronchogen is a tetrapeptide bioregulator (Ala-Glu-Asp-Leu) developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology. It is a tissue-specific bioregulator designed for the bronchi and lungs, promoting normalization of bronchial epithelial cell function. Research suggests benefits for respiratory health, protection against pulmonary aging, and support for bronchopulmonary conditions.
Half-Life
~4–8 hours (HNG)
Short (minutes to hours); bioregulator effects are gene-mediated and longer lasting
Admin Route
SubQ
SubQ, Oral
Research
Typical Dose
2–8 mg
10 mg per day
Frequency
3–5 times per week
Daily for 10–30 days
Key Benefits
  • Neuroprotection against amyloid-beta toxicity (Alzheimer's relevance)
  • Inhibits cellular apoptosis
  • Improves insulin sensitivity
  • Reduces cardiovascular risk markers
  • Anti-inflammatory effects
  • Correlates with longevity in centenarian studies
  • Protects against ischemic injury
  • Potential cancer cell apoptosis sensitization
  • Tissue-specific support for bronchial and lung health
  • Promotes normalization of bronchial epithelial cell function
  • Potential benefits in chronic bronchitis and COPD support
  • Anti-aging effects on pulmonary tissue
  • May reduce frequency of respiratory infections
  • Supports lung function preservation with aging
  • Compatible with other Khavinson bioregulator peptides
Side Effects
  • Injection site irritation
  • Limited human safety data available
  • Generally well tolerated in research studies
  • Mild local reactions at injection site (if injected)
  • No significant systemic side effects reported at standard doses
Stacks With